BR112021019011A2 - Bactérias ácido-láticas de kimchi lactobacillus sakei wikim0109 tendo eficácia para alívio de artrite - Google Patents

Bactérias ácido-láticas de kimchi lactobacillus sakei wikim0109 tendo eficácia para alívio de artrite

Info

Publication number
BR112021019011A2
BR112021019011A2 BR112021019011A BR112021019011A BR112021019011A2 BR 112021019011 A2 BR112021019011 A2 BR 112021019011A2 BR 112021019011 A BR112021019011 A BR 112021019011A BR 112021019011 A BR112021019011 A BR 112021019011A BR 112021019011 A2 BR112021019011 A2 BR 112021019011A2
Authority
BR
Brazil
Prior art keywords
wikim0109
lactobacillus sakei
lactic acid
acid bacteria
efficacy
Prior art date
Application number
BR112021019011A
Other languages
English (en)
Inventor
Jong Choi Hak
Sung Kwon Min
Original Assignee
Korea Food Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Food Res Inst filed Critical Korea Food Res Inst
Publication of BR112021019011A2 publication Critical patent/BR112021019011A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/12—Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/179—Sakei
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Husbandry (AREA)
  • Physiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Sustainable Development (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

bactérias ácido-láticas de kimchi lactobacillus sakei wikim0109 tendo eficácia para alívio de artrite. a presente invenção se refere à nova lactobacillus sakei wikim0109 isolada a partir de kimchi e uma composição contendo a mesma. a lactobacillus sakei wikim0109 de acordo com a presente invenção é uma bactéria ácido-lática tendo uma atividade de inibir a produção de igg e igg2a no sangue e uma atividade de inibir a produção de ifn-?, il-17 e tnf-a e pode ser usada em várias aplicações, tais como para prevenir e melhorar artrite ou melhorar a regulagem intestinal em seres humanos ou animais.
BR112021019011A 2019-03-26 2020-03-20 Bactérias ácido-láticas de kimchi lactobacillus sakei wikim0109 tendo eficácia para alívio de artrite BR112021019011A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020190034211A KR102123505B1 (ko) 2019-03-26 2019-03-26 관절염 저감화 효능을 갖는 김치 유산균 락토바실러스 사케아이 wikim0109
PCT/KR2020/003883 WO2020197188A1 (ko) 2019-03-26 2020-03-20 관절염 저감화 효능을 갖는 김치 유산균 락토바실러스 사케아이 wikim0109

Publications (1)

Publication Number Publication Date
BR112021019011A2 true BR112021019011A2 (pt) 2021-11-30

Family

ID=71405976

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021019011A BR112021019011A2 (pt) 2019-03-26 2020-03-20 Bactérias ácido-láticas de kimchi lactobacillus sakei wikim0109 tendo eficácia para alívio de artrite

Country Status (7)

Country Link
US (1) US20220151253A1 (pt)
EP (1) EP3950928A4 (pt)
JP (1) JP2022528672A (pt)
KR (1) KR102123505B1 (pt)
CN (1) CN113811599A (pt)
BR (1) BR112021019011A2 (pt)
WO (1) WO2020197188A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102392365B1 (ko) * 2020-09-21 2022-05-02 주식회사 비피도 류마티스관절염 개선, 예방 또는 치료를 위한 락토바실러스 사케이 rh1117 균주 및 이를 포함하는 조성물
WO2022139530A1 (ko) * 2020-12-23 2022-06-30 주식회사 리스큐어바이오사이언시스 락토바실러스 사케아이 유래 세포밖 소포체를 유효성분으로 포함하는 자가면역질환의 개선, 예방 또는 치료용 조성물
EP4368193A1 (en) * 2021-07-07 2024-05-15 Liscure Biosciences Inc. Composition for treatment of autoimmune diseases comprising lactobacillus sakei or extracellular vesicles derived therefrom as active ingredient
KR102573675B1 (ko) * 2021-12-28 2023-09-01 한국식품연구원 라티락토바실러스 사케아이 WiKim0142를 포함하는 염증성 질환의 예방, 개선 또는 치료용 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100479719B1 (ko) * 2005-01-29 2005-03-31 주식회사 프로바이오닉 유해 병원성 미생물 생육 억제능 및 항알레르기성을 갖는 신규 내산성 락토바실러스 사케이 Ｐｒｏｂｉｏ-65
TWI346554B (en) * 2008-04-30 2011-08-11 Genmont Biotech Inc Lactobacillus isolates having anti-inflammatory activities and uses of the same
KR20120100608A (ko) * 2011-03-04 2012-09-12 주식회사 알엔에이 면역관련 및 염증성 질환의 예방 및 치료 활성을 갖는 신규한 락토바실러스 사케이(Ｌａｃｔｏｂａｃｉｌｌｕｓ ｓａｋｅｉ) Ｋ101
JP5968655B2 (ja) * 2012-03-21 2016-08-10 石川県公立大学法人 石川県の伝統発酵食品から分離した乳酸菌及びその培養物の機能性とその利用
KR101708173B1 (ko) * 2015-03-06 2017-02-21 경희대학교 산학협력단 혈당 조절 효능을 갖는 신규 유산균 및 이의 용도
WO2017204374A1 (ko) * 2016-05-24 2017-11-30 경희대학교 산학협력단 혈당 조절 효능을 갖는 신규 유산균 및 이의 용도
KR20180060767A (ko) * 2016-11-29 2018-06-07 경남대학교 산학협력단 신규 유산균 락토바실러스 사케이 ch1 및 이를 이용한 발효식품
KR102050265B1 (ko) 2017-03-13 2019-12-02 가톨릭대학교 산학협력단 락토바실러스 아시도필루스를 포함하는 관절염, 섬유증, 대장염 또는 이식거부 반응의 예방 또는 치료용 조성물
KR102098293B1 (ko) * 2017-03-16 2020-04-07 주식회사 알엔에이 약리학적 활성성분이 축적된 미생물 제제
KR101838280B1 (ko) * 2017-05-30 2018-03-14 한국식품연구원 관절염의 개선 활성을 갖는 류코노스톡 시트리움 wikim56 및 이를 포함하는 조성물

Also Published As

Publication number Publication date
CN113811599A (zh) 2021-12-17
EP3950928A1 (en) 2022-02-09
US20220151253A1 (en) 2022-05-19
WO2020197188A1 (ko) 2020-10-01
JP2022528672A (ja) 2022-06-15
KR102123505B1 (ko) 2020-06-17
EP3950928A4 (en) 2023-01-18

Similar Documents

Publication Publication Date Title
BR112021019011A2 (pt) Bactérias ácido-láticas de kimchi lactobacillus sakei wikim0109 tendo eficácia para alívio de artrite
BR112018005195A2 (pt) lactobacillus plantarum lc27, composição farmacêutica para a prevenção ou tratamento de uma ou mais doenças, composição alimentícia para a prevenção ou tratamento de uma ou mais doenças, método de prevenção ou tratamento de uma ou mais doenças, e uso de uma composição que compreende lactobacillus plantarum lc27
BR112022014125A2 (pt) Composições e métodos para controlar micróbios indesejáveis e melhorar saúde animal
MX2018009539A (es) Uso de comunidades microbianas para la salud humana y animal.
DE60328916D1 (de) Bacillus subtilis zur verwendung gegen tierische und menschliche krankheitserreger
BR0214928A (pt) Fagos isolados e seu uso em produtos alimentares e rações para animais
BRPI0902901B8 (pt) bacteriófago e composição antibacteriana, alimento para animais, água potável, desinfetante, agente de limpeza e método para tratamento de doenças infecciosas compreendendo o mesmo
DE60316772D1 (de) Von menschen oder tieren verwenbare diätetische und/oder pharmazeutische zubereitungen, auf basis von probiotischen mikroorganismen
BR112014006768A2 (pt) novo bacteriófago e composição antibacteriana compreendendo o mesmo
AR054730A1 (es) Nuevas bacterias lacticas utiles como probioticos
BR112015006568A2 (pt) composições e bactéria de ácido láctico
BR112013015635A2 (pt) bacteriófago isolado, composição e método de antibiótico para prevenção ou tratamento de doenças infecciosas causadas por uma ou mais linhagens de salmonella, alimentação animal ou água potável e desinfetante ou limpador
BR112022015153A2 (pt) Cepa de cutibacterium acnes e seus usos médicos
BR112015010978A2 (pt) agente para alívio de distúrbio intestinal induzido por estresse contendo cepa de lactobacillus gasseri específica ou produto tratado da mesma
FR3073139B1 (fr) Composition ameliorant le bien-etre des animaux
Bin-Asif et al. The genus Enterococcus and its associated virulent factors
Espeche et al. Physicochemical factors differentially affect the biomass and bacteriocin production by bovine Enterococcus mundtii CRL1656
BR112018074946A2 (pt) produto lácteo fermentado com um teor reduzido de lactose
BR112012027093A2 (pt) prevenção e tratamento de infecção gastrointestinal em mamíferos
BRPI0607234A2 (pt) método para prevenir e/ou tratar infecções vaginais e vulvares
RS20150852A1 (sr) Nova probiotička starter kultura za humanu i animalnu primenu
ATE383163T1 (de) Verwendung von lactobacillus farciminis zur prophylaxe oder behandlung von verdauungserkrankungen
MY196871A (en) Composition which contains lactic acid bacterium as effective component and which is for preventing or ameliorating skin condition deterioration caused by abnormal proliferation of specific bacterium in skin
MX2019006086A (es) Uso de una composicion bacteriana para tratar infecciones en las patas de ungulados.
LV15071A (lv) Kompozīcija subklīniska mastīta ārstēšanai govīm

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2767 DE 16-01-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.